A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS

P Sandercock; E Berge; M Dennis; J Forbes; P Hand; J Kwan; S Lewis; R Lindley; A Neilson; B Thomas; J Wardlaw

A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS

P Sandercock, E Berge, M Dennis, J Forbes, P Hand, J Kwan, S Lewis, R Lindley, A Neilson, B Thomas, J Wardlaw

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-112
Number of pages	112
Journal	Health Technology Assessment
Volume	6
Issue number	26
Publication status	Published - 2002

Keywords

Brain Ischemia
Cost-Benefit Analysis
Diffusion of Innovation
Great Britain
Humans
Neuroprotective Agents
State Medicine
Stroke
Thrombolytic Therapy
Treatment Outcome

Cite this

@article{ea9e77c4ff6245ac83db49d6647ba574,

title = "A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS",

keywords = "Brain Ischemia, Cost-Benefit Analysis, Diffusion of Innovation, Great Britain, Humans, Neuroprotective Agents, State Medicine, Stroke, Thrombolytic Therapy, Treatment Outcome",

author = "P Sandercock and E Berge and M Dennis and J Forbes and P Hand and J Kwan and S Lewis and R Lindley and A Neilson and B Thomas and J Wardlaw",

year = "2002",

language = "English",

volume = "6",

pages = "1--112",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Health Technology Assessment Programme",

number = "26",

}

TY - JOUR

T1 - A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS

AU - Sandercock, P

AU - Berge, E

AU - Dennis, M

AU - Forbes, J

AU - Hand, P

AU - Kwan, J

AU - Lewis, S

AU - Lindley, R

AU - Neilson, A

AU - Thomas, B

AU - Wardlaw, J

PY - 2002

Y1 - 2002

KW - Brain Ischemia

KW - Cost-Benefit Analysis

KW - Diffusion of Innovation

KW - Great Britain

KW - Humans

KW - Neuroprotective Agents

KW - State Medicine

KW - Stroke

KW - Thrombolytic Therapy

KW - Treatment Outcome

M3 - Article

C2 - 12433319

VL - 6

SP - 1

EP - 112

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 26

ER -